Predict your next investment

Venture Capital
hatterasvp.com

See what CB Insights has to offer

Investments

156

Portfolio Exits

24

Funds

11

About Hatteras Venture Partners

Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC with a focus on seed and early stage opportunities in biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine. The firm has approximately $350 million under management in five venture capital funds. Hatteras is led by a seasoned team of entrepreneurs and operators and has a long and successful track record of seed and early stage investing and company formation.

Hatteras Venture Partners Headquarter Location

280 S. Mangum St. Suite 350

Durham, North Carolina, 27701,

United States

919-484-0730

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Hatteras Venture Partners News

Wildflower Health Raises $26M to Support the National Expansion of its Value-Based Maternity Care Offerings

Mar 11, 2022

Wildflower Health, a women’s health solutions company specializing in digital and value-based care has raised$26 million in new funding. The round was led by TT Capital Partners with participation from existing investors, including Providence Ventures, Health Enterprise Partners, Hatteras Venture Partners, and Echo Health Ventures. “Despite increased venture investments in women’s health, providers and payers have struggled to advance true value-based care…

Hatteras Venture Partners Investments

156 Investments

Hatteras Venture Partners has made 156 investments. Their latest investment was in Configo Health as part of their Seed VC on April 4, 2022.

CBI Logo

Hatteras Venture Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/27/2022

Seed VC

Configo Health

$2M

Yes

2

3/8/2022

Series D

Wildflower Health

$26M

No

9

2/4/2022

Series A

Huma.AI

$9.57M

Yes

7

1/7/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

12/2/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/27/2022

3/8/2022

2/4/2022

1/7/2022

12/2/2021

Round

Seed VC

Series D

Series A

Series B

Series A

Company

Configo Health

Wildflower Health

Huma.AI

Subscribe to see more

Subscribe to see more

Amount

$2M

$26M

$9.57M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

9

7

10

10

Hatteras Venture Partners Portfolio Exits

24 Portfolio Exits

Hatteras Venture Partners has 24 portfolio exits. Their latest portfolio exit was AN2 Therapeutics on March 25, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/25/2022

IPO

12

1/11/2022

Acquired

3

1/7/2022

IPO

7

6/30/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

4/28/2021

Merger

Subscribe to see more

Subscribe to see more

10

Date

3/25/2022

1/11/2022

1/7/2022

6/30/2021

4/28/2021

Exit

IPO

Acquired

IPO

IPO

Merger

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

12

3

7

10

10

Hatteras Venture Partners Fund History

11 Fund Histories

Hatteras Venture Partners has 11 funds, including Hatteras Venture Partners VI.

Closing Date

Fund

Fund Type

Status

Amount

Sources

10/15/2020

Hatteras Venture Partners VI

$137.3M

4

1/23/2020

Hatteras Evergreen Private Equity Fund

$27M

1

2/28/2017

Venture Capital Multiplier Fund

Co-Investment VC

Closed

$60M

2

1/5/2017

Hatteras Venture Partners V

Subscribe to see more

Subscribe to see more

$99M

10

1/7/2013

Hatteras Venture Partners IV LP

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

10/15/2020

1/23/2020

2/28/2017

1/5/2017

1/7/2013

Fund

Hatteras Venture Partners VI

Hatteras Evergreen Private Equity Fund

Venture Capital Multiplier Fund

Hatteras Venture Partners V

Hatteras Venture Partners IV LP

Fund Type

Co-Investment VC

Subscribe to see more

Subscribe to see more

Status

Closed

Subscribe to see more

Subscribe to see more

Amount

$137.3M

$27M

$60M

$99M

$99M

Sources

4

1

2

10

10

Hatteras Venture Partners Team

7 Team Members

Hatteras Venture Partners has 7 team members, including current General Partner, John Crumpler.

Name

Work History

Title

Status

John Crumpler

Catalysta Ventures

General Partner

Current

Michael Dial

Silicon Valley Bank, and National Institute of Environmental Health Sciences

General Partner

Current

Robert A. Ingram

General Partner

Current

Kenneth B. Lee

General Partner

Current

Douglas W. Reed

General Partner

Current

Name

John Crumpler

Michael Dial

Robert A. Ingram

Kenneth B. Lee

Douglas W. Reed

Work History

Catalysta Ventures

Silicon Valley Bank, and National Institute of Environmental Health Sciences

Title

General Partner

General Partner

General Partner

General Partner

General Partner

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.